Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Barak Shapira, Ronny Berkovitz, Paola Rosca, Shaul Lev-Ran, Alexander Kaptsan & Yehuda Neumark. (2021) Why Switch? - Motivations for Self-Substitution of Illegal Drugs. Substance Use & Misuse 56:5, pages 627-638.
Read now
Read now
Kirsten Elin Smith & Michele Staton. (2019) Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs?. Substance Abuse 40:2, pages 160-169.
Read now
Read now
Ian P. Albery, Antony C. Moss, Nicola Davidson, S. Mba, Ursula Blaszko & Alexander P. Marchant. (2018) Selective attentional bias for novel psychoactive substance (NPS) and expectancy-related stimuli among nonproblematic NPS users and never NPS users. Journal of Substance Use 23:4, pages 422-428.
Read now
Read now
Kirsten Elin Smith, Amanda M. Bunting, Michele Staton, Robert Walker, Sara Shalash, Erin Winston & Kevin Pangburn. (2017) Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015. Journal of Psychoactive Drugs 49:5, pages 436-445.
Read now
Read now
Wui Ling Chan, David M. Wood & Paul I. Dargan. (2016) Misuse of prescription and over-the-counter medicines in South London nightclubs. Journal of Substance Use 21:5, pages 495-500.
Read now
Read now
Claudio Vidal Giné, Fermín Fernández Calderón & José López Guerrero. (2016) Patterns of use, harm reduction strategies, and their relation to risk behavior and harm in recreational ketamine users. The American Journal of Drug and Alcohol Abuse 42:3, pages 358-369.
Read now
Read now
Alison M Dines, David M Wood, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon, Roumen Sedefov & Paul I Dargan. (2015) Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clinical Toxicology 53:9, pages 893-900.
Read now
Read now
Jonathan Taylor. (2015) The Stimulants of Prohibition: Illegality and New Synthetic Drugs. Territory, Politics, Governance 3:4, pages 407-427.
Read now
Read now
Wui Ling Chan, David Michael Wood & Paul Ivor Dargan. (2015) Significant Misuse of Sildenafil in London Nightclubs. Substance Use & Misuse 50:11, pages 1390-1394.
Read now
Read now
Jan G. C. van Amsterdam, Ton Nabben, Daan Keiman, Gijs Haanschoten & Dirk Korf. (2015) Exploring the Attractiveness of New Psychoactive Substances (NPS) among Experienced Drug Users. Journal of Psychoactive Drugs 47:3, pages 177-181.
Read now
Read now
Kate O'Brien, Caroline Chatwin, Charlie Jenkins & Fiona Measham. (2015) New psychoactive substances and British drug policy: A view from the cyber-psychonauts. Drugs: Education, Prevention and Policy 22:3, pages 217-223.
Read now
Read now
Nick M. Cristiano. (2014) Living in ecstasy: applying the normalization thesis to ecstasy use in Canada. Journal of Substance Use 19:6, pages 405-409.
Read now
Read now
J. R. H Archer, P. I. Dargan, S. Hudson, S. Davies, M. Puchnarewicz, A. T. Kicman, J. Ramsey, F. Measham, M. Wood, A. Johnston & D. M. Wood. (2014) Taking the Pissoir – a novel and reliable way of knowing what drugs are being used in nightclubs. Journal of Substance Use 19:1-2, pages 103-107.
Read now
Read now
J. R. H. Archer, P. I. Dargan, D. M. Wood & A. R. Winstock. (2013) Hospital and prehospital emergency service utilisation as an impact of acute recreational drug and ethanol toxicity. Journal of Substance Use 18:2, pages 129-137.
Read now
Read now
Articles from other publishers (49)
Gabriela Bielecka-Papierz, Ewa Poleszak & Anna Serafko. (2023) Mephedrone – a synthetic derivative of cathinone. Current Issues in Pharmacy and Medical Sciences 36:1, pages 54-64.
Crossref
Crossref
Fiona Measham. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
157
180
.
Karenza Moore. 2022. Drugs, Identity and Stigma. Drugs, Identity and Stigma
25
49
.
John Martin Corkery, Wan-Chu Hung, Hugh Claridge, Christine Goodair, Caroline S Copeland & Fabrizio Schifano. (2021) Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019. Journal of Psychopharmacology 35:11, pages 1324-1348.
Crossref
Crossref
Jonathan P. Caulkins, Laura A. Goyeneche, Lingrong Guo, Kathryn Lenart & Michael Rath. (2021) Outcomes associated with scheduling or up-scheduling controlled substances. International Journal of Drug Policy 91, pages 103110.
Crossref
Crossref
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
307
325
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
295
425
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Barak Shapira, Paola Rosca, Ronny Berkovitz, Igor Gorjaltsan & Yehuda Neumark. (2020) The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ 8, pages e9461.
Crossref
Crossref
Fiona Hutton. 2020. Cultures of Intoxication. Cultures of Intoxication
87
110
.
E Roderick, J Penney, T Murrells, P I Dargan & I J Norman. (2018) Epidemiology of adolescent substance use in Norfolk schools. QJM: An International Journal of Medicine 111:10, pages 699-706.
Crossref
Crossref
Nick Meader, Noreen Mdege & Jim McCambridge. (2018) The public health evidence-base on novel psychoactive substance use: scoping review with narrative synthesis of selected bodies of evidence. Journal of Public Health 40:3, pages e303-e319.
Crossref
Crossref
Dino Luethi, Karolina E. Kolaczynska, Luca Docci, Stephan Krähenbühl, Marius C. Hoener & Matthias E. Liechti. (2018) Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology 134, pages 4-12.
Crossref
Crossref
Marie Claire Van Hout, Annemieke Benschop, Michal Bujalski, Katarzyna Dąbrowska, Zsolt Demetrovics, Katalin Felvinczi, Evelyn Hearne, Susana Henriques, Zsuzsa Kaló, Gerrit Kamphausen, Dirk Korf, Joana Paula Silva, Łukasz Wieczorek & Bernd Werse. (2017) Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries. International Journal of Mental Health and Addiction 16:2, pages 480-495.
Crossref
Crossref
Bernd Werse & Dirk Egger. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
217
228
.
Bobby P. Smyth, Suzi Lyons & Walter Cullen. (2017) Decline in new psychoactive substance use disorders following legislation targeting headshops: Evidence from national addiction treatment data. Drug and Alcohol Review 36:5, pages 609-617.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Caroline Chatwin. (2017) Assessing the ‘added value’ of European policy on new psychoactive substances. International Journal of Drug Policy 40, pages 111-116.
Crossref
Crossref
Rob Ralphs, Lisa Williams, Rebecca Askew & Anna Norton. (2017) Adding Spice to the Porridge11‘Porridge’ is British slang for a prison sentence. E.g. ‘Doing his porridge’. The term is most commonly thought to be an allusion to the fact that porridge is, or used to be, a common food in prison. The term is also thought to be a pun on the much older slang word for prison, ‘stir’.: The development of a synthetic cannabinoid market in an English prison. International Journal of Drug Policy 40, pages 57-69.
Crossref
Crossref
Chris Wilkins, Marta Rychert, Bogumiła Byrska, Marie Claire Van Hout, Ornella Corazza & Andres Roman-Urrestarazu. 2017. Novel Psychoactive Substances. Novel Psychoactive Substances
57
74
.
Anne Lingford-Hughes, Yash Patel, Owen Bowden-Jones, Mike J. Crawford, Paul I. Dargan, Fabiana Gordon, Steve Parrott, Tim Weaver & David M. Wood. (2016) Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial. Trials 17:1.
Crossref
Crossref
Natalie Thurtle, Paul I Dargan, Laura J Hunter, Caitlyn Lovett, John A White & David M Wood. (2016) A comparison of recreational drug use amongst sexual health clinic users in London with existing prevalence data. International Journal of STD & AIDS 27:14, pages 1309-1316.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
80
93
.
J. Penney, P.I. Dargan, J. Padmore, D.M. Wood & I.J. Norman. (2016) Epidemiology of adolescent substance use in London schools. QJM 109:6, pages 405-409.
Crossref
Crossref
Francesco S. Romolo, Paola A. Fiore, Edoardo Bottoni, Simone Cappelletti, Mariarosaria Aromatario & Costantino Ciallella. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
40
49
.
Bernd Werse & Dirk Egger. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
16
.
Johanna J. Nugteren-van Lonkhuyzen, Antoinette J.H.P. van Riel, Tibor M. Brunt & Laura Hondebrink. (2015) Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug and Alcohol Dependence 157, pages 18-27.
Crossref
Crossref
Dina Perrone. 2015. The Handbook of Drugs and Society. The Handbook of Drugs and Society
149
174
.
Anders Ledberg. (2015) The interest in eight new psychoactive substances before and after scheduling. Drug and Alcohol Dependence 152, pages 73-78.
Crossref
Crossref
Máté Kapitány-Fövény, Barbara Mervó, Máté Kertész, Ornella Corazza, Judit Farkas, Gyöngyi Kökönyei, Róbert Urbán & Zsolt Demetrovics. (2015) Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?. Human Psychopharmacology: Clinical and Experimental 30:4, pages 233-243.
Crossref
Crossref
Shwetha Rao, David Wood & Paul Dargan. 2015. Ketamine. Ketamine
103
144
.
Chris Wilkins, Paul Sweetsur & Karl Parker. (2014) The impact of the prohibition of benzylpiperazine (BZP) “legal highs” on the availability, price and strength of BZP in New Zealand. Drug and Alcohol Dependence 144, pages 47-52.
Crossref
Crossref
Nina O'Neill. (2014) Mephedrone and Multiplicity: User Accounts of Effects and Harms. Contemporary Drug Problems 41:3, pages 417-443.
Crossref
Crossref
Lucy Burns, Amanda Roxburgh, Allison Matthews, Raimondo Bruno, Simon Lenton & Joe Van Buskirk. (2014) The rise of new psychoactive substance use in Australia. Drug Testing and Analysis 6:7-8, pages 846-849.
Crossref
Crossref
L J Hunter, P I Dargan, A Benzie, J A White & D M Wood. (2014) Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM. Postgraduate Medical Journal 90:1061, pages 133-138.
Crossref
Crossref
Maria João Valente, Paula Guedes de Pinho, Maria de Lourdes Bastos, Félix Carvalho & Márcia Carvalho. (2013) Khat and synthetic cathinones: a review. Archives of Toxicology 88:1, pages 15-45.
Crossref
Crossref
T. Yamamoto, A. Kawsar, J. Ramsey, P. I. Dargan & D. M. Wood. (2013) Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs. QJM 106:12, pages 1111-1117.
Crossref
Crossref
Brian C. Kelly, Brooke E. Wells, Mark Pawson, Amy Leclair, Jeffrey T. Parsons & Sarit A. Golub. (2013) Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug and Alcohol Review 32:6, pages 588-593.
Crossref
Crossref
Sinead E. Shortall, Alice E. Macerola, Rabbi T.R. Swaby, Rebecca Jayson, Chantal Korsah, Katharine E. Pillidge, Peter M. Wigmore, Francis J.P. Ebling, A. Richard Green, Kevin C.F. Fone & Madeleine V. King. (2013) Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. European Neuropsychopharmacology 23:9, pages 1085-1095.
Crossref
Crossref
Pierluigi Simonato, Ornella Corazza, Paolo Santonastaso, John Corkery, Paolo Deluca, Zoe Davey, Ursula Blaszko & Fabrizio Schifano. (2013) Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Human Psychopharmacology: Clinical and Experimental 28:4, pages 324-331.
Crossref
Crossref
David McQuade, Simon Hudson, Paul I. Dargan & David M. Wood. (2012) First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. European Journal of Clinical Pharmacology 69:3, pages 373-376.
Crossref
Crossref
Daniela A. Herzig, Rowan Brooks & Christine Mohr. (2013) Inferring about individual drug and schizotypy effects on cognitive functioning in polydrug using mephedrone users before and after clubbing. Human Psychopharmacology: Clinical and Experimental 28:2, pages 168-182.
Crossref
Crossref
Karenza Moore, Paul I. Dargan, David M. Wood & Fiona Measham. (2013) Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation The relationship between Mephedrone, Ecstasy and Cocaine. European Addiction Research 19:5, pages 276-282.
Crossref
Crossref
Qi Li, Wai Man Chan, John A. Rudd, Chun Mei Wang, Phoebe Y.H. Lam, Maria Sen Mun Wai, David M. Wood, Paul I. Dargan & David T. Yew. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
285
316
.
Fiona Measham. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
105
127
.
David M. Wood & Paul I. Dargan. (2012) Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 227-233.
Crossref
Crossref
Rebekah Brennan & Marie Claire Van Hout. (2012) Miaow miaow: a review of the new psychoactive drug mephedrone. Drugs and Alcohol Today 12:4, pages 241-253.
Crossref
Crossref
D. M. Wood & P. I. Dargan. (2012) Understanding How Data Triangulation Identifies Acute Toxicity of Novel Psychoactive Drugs. Journal of Medical Toxicology 8:3, pages 300-303.
Crossref
Crossref
David M. Wood & Paul I. Dargan. (2012) Novel Psychoactive Substances. Therapeutic Drug Monitoring 34:4, pages 363-367.
Crossref
Crossref